Partners
ORYZON to participate in upcoming events in September and October
Oryzon Genomics S.A., a European biopharmaceutical leader in epigenetics, will participate in several key events in September and October, including BIOSPAIN 2025 in Barcelona and the Sachs Annual Biotech in Europe Forum in Basel.
Corporate
Oryzon Genomics S.A., a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that its management will participate at the following upcoming events:
Drug Discovery Innovation Programme, September 25-26
- Location: Intercontinental Hotel, Barcelona, Spain
Paris Midcap Event 2025, September 30-October 1
- Location: Four Seasons George V, Paris, France
BME Investor Access Event 2025, October 7
- Location: Maison de la Chimie, Paris, France
BIOSPAIN 2025, October 7-9
- Location: Fira de Barcelona – Montjuïc, Barcelona, Spain
25th Sachs Annual Biotech in Europe Forum 2025, October 8-9
- Location: Mövenpick Hotel, Basel, Switzerland
- Presentation type: Company presentation
- Presentation date and time: October 8, 13:45 CET
Oryzon management will be available for one-on-one meetings during the conferences.